InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by SCHMERTZLER MICHAEL, Director. Director active across 1 companies, notably PTC Therapeutics, INC.. In total, 2 filings have been published. The latest transaction was disclosed on 7 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
06,400 shares0
Common Stock
SEC:0001179110-22-000391·
06,400 shares0
Common Stock
SEC:0001179110-22-000391:0·
2 of 2 declarations
About SCHMERTZLER MICHAEL
Michael Schmertzler is a Director at PTC Therapeutics, Inc. As a board member, he contributes to the governance and strategy of the company. His experience in the biopharmaceutical sector allows him to provide valuable insights into the development of new treatments.
